Literature DB >> 6866717

In vitro testing of controlled release theophylline preparations: Theolair, Theograd and Theolin.

J P Crombeen, C J De Blaey.   

Abstract

Three dissolution methods, i.e. a paddle type, the USP disintegration and a column method, were used to characterize the release from three controlled release theophylline preparations, i.e. Theolair Retard 250, Theolin Retard 300 and Theograd 350. The release profiles proved to be dependent upon agitation intensity and pH or a combination of both, but the sensitivity towards these variables differed markedly between the products tested.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866717     DOI: 10.1007/bf01960078

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  14 in total

1.  Rate of release of medicaments from ointment bases containing drugs in suspension.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1961-10       Impact factor: 3.534

2.  Influence of shape factors on kinetics of drug release from matrix tablets. I. Theoretical.

Authors:  J Cobby; M Mayersohn; G C Walker
Journal:  J Pharm Sci       Date:  1974-05       Impact factor: 3.534

3.  In vitro assessment of dissolution kinetics: description and evaluation of a column-type method.

Authors:  F Langenbucher
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

4.  [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].

Authors:  G F Schneider; G U Heese; H J Huber; N Janzen; H Jünger; C Moser; F Stanislaus
Journal:  Arzneimittelforschung       Date:  1981

5.  The relation of product formulation to absorption of oral theophylline.

Authors:  M Weinberger; L Hendeles; L Bighley
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

6.  Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease.

Authors:  R K Elwood; J G Kelly; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

7.  Pharmacokinetics of a sustained-release theophylline formulation.

Authors:  P W Trembath; S W Boobois
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

8.  Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.

Authors:  R A Upton; L Sansom; T W Guentert; J R Powell; J F Thiercelin; V P Shah; P E Coates; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1980-06

9.  Theophylline bioavailability following oral administration of six sustained-release preparations.

Authors:  D L Spangler; D D Kalof; F L Bloom; H J Wittig
Journal:  Ann Allergy       Date:  1978-01

10.  Evaluation of the absorption from some commercial sustained-release theophylline products.

Authors:  R A Upton; J F Thiercelin; T W Guentert; L Sansom; J R Powell; P E Coates; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1980-04
View more
  2 in total

Review 1.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

Review 2.  Food interactions with sustained-release theophylline preparations. A review.

Authors:  J H Jonkman
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.